One-year clinical outcomes of patients with versus without acute coronary syndrome with 3-month duration of dual antiplatelet therapy after everolimus-eluting stent implantation

There has been no previous prospective study evaluating 3-month dual antiplatelet therapy (DAPT) after cobalt-chromium everolimus-eluting stent (CoCr-EES) implantation in patients with acute coronary syndrome (ACS). The STOPDAPT trial is a prospective multi-center single-arm study evaluating 3-month...

Descripción completa

Detalles Bibliográficos
Autores principales: Natsuaki, Masahiro, Morimoto, Takeshi, Yamamoto, Erika, Watanabe, Hirotoshi, Furukawa, Yutaka, Abe, Mitsuru, Nakao, Koichi, Ishikawa, Tetsuya, Kawai, Kazuya, Yunoki, Kei, Shimizu, Shogo, Akao, Masaharu, Miki, Shinji, Yamamoto, Masashi, Okada, Hisayuki, Hoshino, Kozo, Kadota, Kazushige, Morino, Yoshihiro, Hanaoka, Keiichi Igarashi, Tanabe, Kengo, Kozuma, Ken, Kimura, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094877/
https://www.ncbi.nlm.nih.gov/pubmed/32210433
http://dx.doi.org/10.1371/journal.pone.0227612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094877/
https://www.ncbi.nlm.nih.gov/pubmed/32210433
http://dx.doi.org/10.1371/journal.pone.0227612

Ejemplares similares